This document discusses the history and types of stem cells and their applications in regenerative medicine. It defines stem cells as unspecialized cells that can differentiate into other cell types and self-renew. It describes the different types of stem cells based on their potency, from totipotent stem cells found in early embryos to unipotent adult stem cells. The document outlines milestones in the development of organ and cell transplantation, from early blood transfusions to modern bone marrow transplantation. It discusses the potential of stem cells to treat diseases and conditions like Parkinson's, Alzheimer's, spinal cord injury, and diabetes.
WHAT IS THERAPEUTIC CLONING?#SciChallenge2017giulia api
Cloning is the process of creating a genetically identical copy of an organism. There are several types of cloning including reproductive cloning to create an organism with identical genetics to a donor, therapeutic cloning to create stem cells for medical research and treatment, and productive cloning to create selected organs or tissues. Therapeutic cloning involves transferring the nucleus of a donor cell into an egg cell to produce stem cells that can be used to treat degenerative diseases like diabetes, Alzheimer's, and Parkinson's. Stem cells have the potential to differentiate into many cell types and are a promising area of research for regenerative medicine and disease treatment.
Stem cells are undifferentiated cells that can differentiate into specialized cells and divide to produce more stem cells. There are two main types: embryonic stem cells isolated from blastocysts and adult stem cells found in tissues. Stem cells are characterized by their ability to self-renew and their potency to differentiate. Stem cell therapy uses stem cells to treat diseases by promoting tissue regeneration when stem cells differentiate into the target tissue upon transplantation. While stem cell therapy holds promise, ethical issues surround the use of embryonic stem cells and challenges remain in obtaining cells and ensuring successful transplantation and treatment of diseases.
Stem cells have the ability to differentiate into specialized cell types. Key developmental genes in embryonic stem cells exist in a "bivalent" chromatin state, marked by both active and repressive histone modifications. This "poised" state allows genes to be either activated or repressed during differentiation. In differentiated cells, these bivalent domains resolve into monovalent states corresponding to gene expression. Maintaining developmental genes in a bivalent state is important for cell fate decisions during differentiation.
Stem cells can replace diseased tissue and are used in bone marrow transplants for diseases like leukemia. There are three ways to achieve pluripotency: embryonic stem cells from the blastocyst, reprogrammed stem cells through somatic cell nuclear transfer or induced pluripotency, and induced pluripotent stem cells derived from adult skin cells which provide a complete immunological match for therapy.
This document discusses stem cell technology in reproduction. It defines different types of stem cells including totipotent, pluripotent, multipotent and progenitor cells. It describes embryonic stem cells, adult stem cells, cord blood stem cells and amniotic fluid stem cells. Induced pluripotent stem cells are discussed. The use of stem cells in neo-oogenesis, testicular and ovarian infertility, tissue engineering of reproductive organs, and animal production is summarized. Key milestones in stem cell research for veterinary reproduction are highlighted. The document concludes that stem cell technology could revolutionize medicine through techniques like preservation of germ lines and stem cell transplantation.
Embryonic stem cells can develop into any cell type and may be useful for treating diseases. Scientists want to clone human embryos to extract stem cells, which could be used to generate new cells for patients with conditions like Parkinson's disease. Therapeutic cloning involves cloning an embryo with the patient's genes to avoid rejection of foreign cells. Some scientists support this approach because stem cells could be used to generate replacement cells for damaged tissues.
WHAT IS THERAPEUTIC CLONING?#SciChallenge2017giulia api
Cloning is the process of creating a genetically identical copy of an organism. There are several types of cloning including reproductive cloning to create an organism with identical genetics to a donor, therapeutic cloning to create stem cells for medical research and treatment, and productive cloning to create selected organs or tissues. Therapeutic cloning involves transferring the nucleus of a donor cell into an egg cell to produce stem cells that can be used to treat degenerative diseases like diabetes, Alzheimer's, and Parkinson's. Stem cells have the potential to differentiate into many cell types and are a promising area of research for regenerative medicine and disease treatment.
Stem cells are undifferentiated cells that can differentiate into specialized cells and divide to produce more stem cells. There are two main types: embryonic stem cells isolated from blastocysts and adult stem cells found in tissues. Stem cells are characterized by their ability to self-renew and their potency to differentiate. Stem cell therapy uses stem cells to treat diseases by promoting tissue regeneration when stem cells differentiate into the target tissue upon transplantation. While stem cell therapy holds promise, ethical issues surround the use of embryonic stem cells and challenges remain in obtaining cells and ensuring successful transplantation and treatment of diseases.
Stem cells have the ability to differentiate into specialized cell types. Key developmental genes in embryonic stem cells exist in a "bivalent" chromatin state, marked by both active and repressive histone modifications. This "poised" state allows genes to be either activated or repressed during differentiation. In differentiated cells, these bivalent domains resolve into monovalent states corresponding to gene expression. Maintaining developmental genes in a bivalent state is important for cell fate decisions during differentiation.
Stem cells can replace diseased tissue and are used in bone marrow transplants for diseases like leukemia. There are three ways to achieve pluripotency: embryonic stem cells from the blastocyst, reprogrammed stem cells through somatic cell nuclear transfer or induced pluripotency, and induced pluripotent stem cells derived from adult skin cells which provide a complete immunological match for therapy.
This document discusses stem cell technology in reproduction. It defines different types of stem cells including totipotent, pluripotent, multipotent and progenitor cells. It describes embryonic stem cells, adult stem cells, cord blood stem cells and amniotic fluid stem cells. Induced pluripotent stem cells are discussed. The use of stem cells in neo-oogenesis, testicular and ovarian infertility, tissue engineering of reproductive organs, and animal production is summarized. Key milestones in stem cell research for veterinary reproduction are highlighted. The document concludes that stem cell technology could revolutionize medicine through techniques like preservation of germ lines and stem cell transplantation.
Embryonic stem cells can develop into any cell type and may be useful for treating diseases. Scientists want to clone human embryos to extract stem cells, which could be used to generate new cells for patients with conditions like Parkinson's disease. Therapeutic cloning involves cloning an embryo with the patient's genes to avoid rejection of foreign cells. Some scientists support this approach because stem cells could be used to generate replacement cells for damaged tissues.
Stem cells can differentiate into many specialized cell types and can divide to produce more stem cells. The main types are embryonic, adult, and induced pluripotent stem cells. Embryonic stem cells are derived from the inner cell mass of blastocysts and are pluripotent, while adult stem cells are tissue-specific and multipotent. In 2007, induced pluripotent stem cells were discovered whereby adult cells can be reprogrammed into pluripotent stem cells. Stem cell research continues to provide potential treatments for diseases.
This document discusses adult stem cell therapy. It defines adult stem cells as undifferentiated cells found throughout the body that can multiply to replenish dying cells and regenerate damaged tissues. It lists several types of adult stem cells and their key properties of self-renewal and potency. Adult stem cells are located in many organs and tissues. Therapies involve harvesting or culturing adult stem cells of a specific lineage. Adult stem cell therapies show potential for treating conditions like leukemia and for regenerative medicine applications. However, limitations include difficulty isolating and maintaining some adult stem cell types in culture.
Stem cells are undifferentiated cells that can differentiate into various cell types and serve as a repair system for the body. There are several types of stem cells. Embryonic stem cells are the most versatile and found in early-stage embryos, while adult stem cells are found in tissues and can differentiate into multiple cell types. Mesenchymal stem cells are multipotent and can differentiate into bone, cartilage, and fat cells. Induced pluripotent stem cells are generated from adult cells that have been genetically reprogrammed. The potential medical uses of stem cells are debated due to ethical issues around embryonic stem cell research.
From Bench to Bedside: Research and Clinical Applications of Induced Pluripot...TheresaGold
Since the isolation of embryonic stem cells in 1998, stem cell research has been considered the most promising research platform for developmental studies, disease treatment, tissue repair engineering, and regenerative medicine. However, embryonic stem cell research has been widely regulated and restricted due to the ethical issues surrounding research using embryonic tissue. Induced pluripotent stem cells (iPS cells) are stems cells that are derived through the genetic reprogramming of a somatic cell. iPS cells are nearly identical to embryonic stem cells, possessing the potential to give rise to every cell type in an organism, with the exception of extraembryonic tissues. Consequently, induced pluripotent stem cells promise the same research and clinical benefits as embryonic stem cells, without the ethical concerns. This presentation explores the process of generating induced pluripotent stem cells and investigates potential applications of induced pluripotent stem cells in both a research and clinical setting.
stem cell research is yet to be advanced , once fully developed can alleviate human suffering, this ppt reviews the contemporary evidence, pitfalls and challenges
Introduction to Cell Biology and Stem Cellsrunfaster89
This document provides an overview of cell biology concepts covered in an AP Biology course. It defines cells as the basic unit of life and discusses both prokaryotic and eukaryotic cell structures. Unicellular and multicellular organisms are described as performing the basic functions of life. The document outlines cell specialization and differentiation in complex organisms. Sources and therapeutic uses of stem cells are also summarized, along with the ethical considerations surrounding embryonic stem cell research.
In this presentation, I talk about the various forms of chimerism observed in humans like tetragametic chimerism, twin chimerism and fetomaternal microchimerism and some case studies related to chimerism.
Stem cells can develop into many cell types and may help treat diseases. Therapeutic cloning uses stem cells from cloned embryos to generate patient-matched cells for transplantation without immunorejection. While this research offers medical benefits, it also raises ethical concerns and some argue it undermines human dignity. Views on funding and regulating this research differ, as seen in debates around related bills in the U.S. Congress and state legislatures. Public opinion polls show most support therapeutic cloning if it is not tied to embryo destruction.
Cancer cells have a binary identity - one originating from outside immune cells like macrophages, making them non-self. Cancer cells have accumulated so many mutations that their group identity wants to live exceptionally and irregularly, transferred from outside. The main point is that cancer cells depend on inadequate energy, which increases mutations. Malignancy occurs with increasing mutations due to low energy. Benign conditions are possible with high energy and low mutations. Cancer cells are selfish, parasitic, irregular, immortal and immature due to their transferred mutated group identity from outside. Normal DNA sequences cannot be transcribed or expressed due to inadequate energy.
Stem cells are unspecialized cells that can divide and renew themselves. Totipotent stem cells can form all cell types, while pluripotent stem cells like embryonic stem cells can form any cell type in the body. Dr. Shinya Yamanaka won the 2012 Nobel Prize for discovering that mature cells can be induced to become pluripotent stem cells (iPS cells) using cytokines and growth factors. iPS cells can be used for regenerative medicine by replacing damaged cells, developing new drugs by testing potential treatments on patient-specific cells, and studying genetic diseases.
What is Stem Cell ?
History of Stem Cells ?
Stages of Embryogenesis
Blastocyst Diagram
Three types of stem cells
Differentiation of ESC
Adult Stem Cells
Bone Marrow
Umbilical cord stem cells
Factors known to affect stem cells
Niche cells activates Stem cells
Regenerative Medicine : Indian Scenario
Latest developments in stem cell therapy 2015CryoSave Arabia
The document discusses developments in stem cell therapy, noting that the number of hematopoietic stem cell transplants has increased 35% over 5 years to nearly 78,000 performed worldwide in 2014. Transplants using umbilical cord blood stem cells have also risen dramatically, from 11,000 in 2009 to over 30,000. Stem cells can be collected from bone marrow, umbilical cord blood, or peripheral blood and have been used since the 1950s to treat over 80 diseases including various cancers, blood disorders, and autoimmune conditions. The document encourages banking umbilical cord blood privately or donating it publicly given the potential future medical uses.
Cloning involves making a genetic duplicate of an organism with the same DNA. It can be done through somatic cell nuclear transfer where the nucleus of an adult cell is transferred into an egg cell with its nucleus removed. The reconstructed egg is stimulated to divide through electric currents or chemicals and develops into an embryo. Species that have been cloned include carp, mice, sheep, monkeys, pigs, and horses. Cloning can be used for reproductive purposes or to generate human embryos for medical research.
This document discusses human cloning and its various types. There are two main types of cloning: therapeutic cloning, which uses stem cells for medical research purposes by cloning embryos and collecting stem cells, and reproductive cloning, which would clone entire humans by transferring cloned embryo into a uterus. Therapeutic cloning is more accepted but still controversial due to the embryo destruction. Reproductive cloning is deemed unethical as it would create human life solely as an organ donor. The document also notes debates around the ethics of human cloning.
This document discusses the history and potential applications of stem cell research. It begins with a timeline of important developments in stem cell research from 1998 to 2004. It then defines stem cells as unspecialized cells that can divide and differentiate into other cell types. The document outlines the main types of stem cells: embryonic, adult, and induced pluripotent stem cells. It provides examples of how stem cells may be used to treat diseases like cancer, diabetes, and heart disease. The document concludes by discussing the technical challenges of stem cell research and the ethical controversies surrounding the use of embryonic stem cells.
Stem cell therapy involves using stem cells to treat diseases. There are two main types of stem cells - embryonic stem cells which are pluripotent and derived from embryos, and adult stem cells which are multipotent and found in tissues. Stem cell therapy shows promise for treating conditions like leukemia, neurodegenerative diseases, brain/spinal cord injuries, heart disease, blindness, diabetes, and more. Gene therapy aims to treat genetic disorders by inserting, altering or removing genes to correct defective genes. It involves approaches like replacing an abnormal gene with a normal gene through gene transfer methods using physical, chemical or biological vectors like retroviruses.
Stem cells are cells that can differentiate into other types of cells and can self-renew to produce more stem cells. There are two main types: embryonic stem cells, which are pluripotent and found in early stage embryos, and somatic or adult stem cells, which are multipotent and found in adult tissues. Stem cells are studied for their potential uses such as regenerating damaged tissues to treat diseases like diabetes or paralysis.
This document provides an overview of stem cell research including different types of stem cells, their potential medical applications, and the processes of embryonic stem cell derivation and therapeutic cloning. It discusses embryonic stem cells' ability to differentiate into any cell type compared to adult stem cells' more limited potential. Current research aims to develop stem cell therapies for conditions like diabetes, spinal cord injury, and heart disease. However, significant challenges remain regarding controlling stem cell behavior and ensuring therapies are long-lasting without tumor formation.
Transplant immunity discusses the history and immunological basis of organ transplantation. It provides an outline of topics including the types of rejection, effector mechanisms, laboratory workup, immunosuppressive therapy, and individual transplant procedures. The document traces the evolution of the field from early mythology to modern transplantation techniques and immunosuppression, highlighting key discoveries like the identification of MHC antigens and development of drugs that enabled successful unrelated donor transplants.
Stem cells can differentiate into many specialized cell types and can divide to produce more stem cells. The main types are embryonic, adult, and induced pluripotent stem cells. Embryonic stem cells are derived from the inner cell mass of blastocysts and are pluripotent, while adult stem cells are tissue-specific and multipotent. In 2007, induced pluripotent stem cells were discovered whereby adult cells can be reprogrammed into pluripotent stem cells. Stem cell research continues to provide potential treatments for diseases.
This document discusses adult stem cell therapy. It defines adult stem cells as undifferentiated cells found throughout the body that can multiply to replenish dying cells and regenerate damaged tissues. It lists several types of adult stem cells and their key properties of self-renewal and potency. Adult stem cells are located in many organs and tissues. Therapies involve harvesting or culturing adult stem cells of a specific lineage. Adult stem cell therapies show potential for treating conditions like leukemia and for regenerative medicine applications. However, limitations include difficulty isolating and maintaining some adult stem cell types in culture.
Stem cells are undifferentiated cells that can differentiate into various cell types and serve as a repair system for the body. There are several types of stem cells. Embryonic stem cells are the most versatile and found in early-stage embryos, while adult stem cells are found in tissues and can differentiate into multiple cell types. Mesenchymal stem cells are multipotent and can differentiate into bone, cartilage, and fat cells. Induced pluripotent stem cells are generated from adult cells that have been genetically reprogrammed. The potential medical uses of stem cells are debated due to ethical issues around embryonic stem cell research.
From Bench to Bedside: Research and Clinical Applications of Induced Pluripot...TheresaGold
Since the isolation of embryonic stem cells in 1998, stem cell research has been considered the most promising research platform for developmental studies, disease treatment, tissue repair engineering, and regenerative medicine. However, embryonic stem cell research has been widely regulated and restricted due to the ethical issues surrounding research using embryonic tissue. Induced pluripotent stem cells (iPS cells) are stems cells that are derived through the genetic reprogramming of a somatic cell. iPS cells are nearly identical to embryonic stem cells, possessing the potential to give rise to every cell type in an organism, with the exception of extraembryonic tissues. Consequently, induced pluripotent stem cells promise the same research and clinical benefits as embryonic stem cells, without the ethical concerns. This presentation explores the process of generating induced pluripotent stem cells and investigates potential applications of induced pluripotent stem cells in both a research and clinical setting.
stem cell research is yet to be advanced , once fully developed can alleviate human suffering, this ppt reviews the contemporary evidence, pitfalls and challenges
Introduction to Cell Biology and Stem Cellsrunfaster89
This document provides an overview of cell biology concepts covered in an AP Biology course. It defines cells as the basic unit of life and discusses both prokaryotic and eukaryotic cell structures. Unicellular and multicellular organisms are described as performing the basic functions of life. The document outlines cell specialization and differentiation in complex organisms. Sources and therapeutic uses of stem cells are also summarized, along with the ethical considerations surrounding embryonic stem cell research.
In this presentation, I talk about the various forms of chimerism observed in humans like tetragametic chimerism, twin chimerism and fetomaternal microchimerism and some case studies related to chimerism.
Stem cells can develop into many cell types and may help treat diseases. Therapeutic cloning uses stem cells from cloned embryos to generate patient-matched cells for transplantation without immunorejection. While this research offers medical benefits, it also raises ethical concerns and some argue it undermines human dignity. Views on funding and regulating this research differ, as seen in debates around related bills in the U.S. Congress and state legislatures. Public opinion polls show most support therapeutic cloning if it is not tied to embryo destruction.
Cancer cells have a binary identity - one originating from outside immune cells like macrophages, making them non-self. Cancer cells have accumulated so many mutations that their group identity wants to live exceptionally and irregularly, transferred from outside. The main point is that cancer cells depend on inadequate energy, which increases mutations. Malignancy occurs with increasing mutations due to low energy. Benign conditions are possible with high energy and low mutations. Cancer cells are selfish, parasitic, irregular, immortal and immature due to their transferred mutated group identity from outside. Normal DNA sequences cannot be transcribed or expressed due to inadequate energy.
Stem cells are unspecialized cells that can divide and renew themselves. Totipotent stem cells can form all cell types, while pluripotent stem cells like embryonic stem cells can form any cell type in the body. Dr. Shinya Yamanaka won the 2012 Nobel Prize for discovering that mature cells can be induced to become pluripotent stem cells (iPS cells) using cytokines and growth factors. iPS cells can be used for regenerative medicine by replacing damaged cells, developing new drugs by testing potential treatments on patient-specific cells, and studying genetic diseases.
What is Stem Cell ?
History of Stem Cells ?
Stages of Embryogenesis
Blastocyst Diagram
Three types of stem cells
Differentiation of ESC
Adult Stem Cells
Bone Marrow
Umbilical cord stem cells
Factors known to affect stem cells
Niche cells activates Stem cells
Regenerative Medicine : Indian Scenario
Latest developments in stem cell therapy 2015CryoSave Arabia
The document discusses developments in stem cell therapy, noting that the number of hematopoietic stem cell transplants has increased 35% over 5 years to nearly 78,000 performed worldwide in 2014. Transplants using umbilical cord blood stem cells have also risen dramatically, from 11,000 in 2009 to over 30,000. Stem cells can be collected from bone marrow, umbilical cord blood, or peripheral blood and have been used since the 1950s to treat over 80 diseases including various cancers, blood disorders, and autoimmune conditions. The document encourages banking umbilical cord blood privately or donating it publicly given the potential future medical uses.
Cloning involves making a genetic duplicate of an organism with the same DNA. It can be done through somatic cell nuclear transfer where the nucleus of an adult cell is transferred into an egg cell with its nucleus removed. The reconstructed egg is stimulated to divide through electric currents or chemicals and develops into an embryo. Species that have been cloned include carp, mice, sheep, monkeys, pigs, and horses. Cloning can be used for reproductive purposes or to generate human embryos for medical research.
This document discusses human cloning and its various types. There are two main types of cloning: therapeutic cloning, which uses stem cells for medical research purposes by cloning embryos and collecting stem cells, and reproductive cloning, which would clone entire humans by transferring cloned embryo into a uterus. Therapeutic cloning is more accepted but still controversial due to the embryo destruction. Reproductive cloning is deemed unethical as it would create human life solely as an organ donor. The document also notes debates around the ethics of human cloning.
This document discusses the history and potential applications of stem cell research. It begins with a timeline of important developments in stem cell research from 1998 to 2004. It then defines stem cells as unspecialized cells that can divide and differentiate into other cell types. The document outlines the main types of stem cells: embryonic, adult, and induced pluripotent stem cells. It provides examples of how stem cells may be used to treat diseases like cancer, diabetes, and heart disease. The document concludes by discussing the technical challenges of stem cell research and the ethical controversies surrounding the use of embryonic stem cells.
Stem cell therapy involves using stem cells to treat diseases. There are two main types of stem cells - embryonic stem cells which are pluripotent and derived from embryos, and adult stem cells which are multipotent and found in tissues. Stem cell therapy shows promise for treating conditions like leukemia, neurodegenerative diseases, brain/spinal cord injuries, heart disease, blindness, diabetes, and more. Gene therapy aims to treat genetic disorders by inserting, altering or removing genes to correct defective genes. It involves approaches like replacing an abnormal gene with a normal gene through gene transfer methods using physical, chemical or biological vectors like retroviruses.
Stem cells are cells that can differentiate into other types of cells and can self-renew to produce more stem cells. There are two main types: embryonic stem cells, which are pluripotent and found in early stage embryos, and somatic or adult stem cells, which are multipotent and found in adult tissues. Stem cells are studied for their potential uses such as regenerating damaged tissues to treat diseases like diabetes or paralysis.
This document provides an overview of stem cell research including different types of stem cells, their potential medical applications, and the processes of embryonic stem cell derivation and therapeutic cloning. It discusses embryonic stem cells' ability to differentiate into any cell type compared to adult stem cells' more limited potential. Current research aims to develop stem cell therapies for conditions like diabetes, spinal cord injury, and heart disease. However, significant challenges remain regarding controlling stem cell behavior and ensuring therapies are long-lasting without tumor formation.
Transplant immunity discusses the history and immunological basis of organ transplantation. It provides an outline of topics including the types of rejection, effector mechanisms, laboratory workup, immunosuppressive therapy, and individual transplant procedures. The document traces the evolution of the field from early mythology to modern transplantation techniques and immunosuppression, highlighting key discoveries like the identification of MHC antigens and development of drugs that enabled successful unrelated donor transplants.
Blood production agency. all types of blood cellls are produced in it. to understand it is the need of this era. it also will help in the physiology of blood making mechanism.
Stem cells are cells that can differentiate into other cell types and can self-renew to produce more stem cells. There are several types of stem cells including embryonic stem cells, which are pluripotent and can become any cell type, and adult stem cells, which are multipotent and can differentiate into a limited number of cell types. Umbilical cord blood is a rich source of hematopoietic stem cells and is commonly collected after birth to treat blood disorders. It has advantages over bone marrow as a stem cell source as collection is non-invasive, a perfect tissue match is not required, and cells are younger and more adaptable. Over 15,000 cord blood transplants have been performed worldwide to treat over 70
Kidney transplantation from myth to reality , ajman meeting 2013 mayAyman Seddik
This document discusses the history of organ transplantation from ancient myths to modern practice. It begins with stories from ancient civilizations featuring organs exchanged between humans and animals. Early experiments in the 1900s involved the first animal-to-animal and human kidney transplants. Major advances included defining brain death criteria, developing immunosuppressive drugs like cyclosporine, and establishing criteria for living and deceased donors. Today kidney transplantation has better long-term survival outcomes than dialysis and is an established treatment for end-stage renal disease.
Cell theory states that the cell is the basic unit of life. All living things are made up of one or more cells. Key contributors to cell theory included Schleiden, Schwann, and Virchow. Schleiden established that plants are made of cells. Schwann proposed that animal tissues are also made of cells. Virchow proposed that cells only come from pre-existing cells. The nucleus and cytoplasm are key parts of the cell. Cells divide through mitosis and meiosis to produce new cells. Mendel's laws of inheritance established genetics and heredity are transmitted through discrete units (genes). The theory of blending inheritance was disproven and could not explain observed patterns of inheritance.
Indian Dental Academy: will be one of the most relevant and exciting training center with best faculty and flexible training programs for dental professionals who wish to advance in their dental practice,Offers certified courses in Dental implants,Orthodontics,Endodontics,Cosmetic Dentistry, Prosthetic Dentistry, Periodontics and General Dentistry.
Kidney transplantation from myth to reality , ajman meeting 2013 mayAyman Seddik
This document discusses the history of organ transplantation from ancient myths to modern practices. It covers early experimental transplant attempts in the 1900s-1950s using animal organs that failed due to rejection. The first successful kidney transplant was performed in 1954 between identical twins. Cyclosporine revolutionized transplantation in the 1980s by reducing rejection rates and allowing non-renal organ transplants. Now transplantation offers superior long-term survival compared to dialysis and over 800,000 transplants have been performed worldwide with records of 45 years for kidney grafts.
Henrietta Lacks' cervical cancer cells, taken without her consent in 1951, were the first human cells successfully cloned. Known as HeLa cells, they have been invaluable for medical research, including the development of the polio vaccine and cancer treatments. However, Lacks' family did not find out about her immortal cells for decades and were never compensated for the cell line's contributions, which generated billions in profits. Her story highlights the ethical issues around informed consent and benefit-sharing that are still grappled with today in medical research involving human cells and tissue.
Regenerative medicine aims to develop effective methods to generate replacement cells from stem cells to treat diseases. It has the potential to heal damaged tissues and organs through techniques like tissue engineering and 3D bioprinting. Current therapies include skin grafts for burns and tissue-engineered bladders and blood vessels. Challenges include the difficulty obtaining stem cells, high costs, and safety issues with some methods. The future of regenerative medicine could see treatments for conditions like diabetes, heart disease, and spinal cord injuries.
Biology lesson 1 " CELL THE FUNDAMENTAL UNIT OF LIFE "Rohitsatyaanand
Cell is the basic structural and functional unit of living organisms. All living things are made up of one or more cells, and all cells arise from pre-existing cells through division. The cell theory states that the cell is the fundamental unit of structure and function in living things. Cells were first observed in the 1600s and the cell theory was developed over many years by scientists in the 1800s through observations of plant and animal cells under early microscopes. Cells vary greatly in size, shape, and structure depending on their function in unicellular or multicellular organisms.
Stem cells are cells that can differentiate into other types of cells and can self-renew through cell division. There are two main types: embryonic stem cells found in blastocysts and adult stem cells found in adult tissues. Stem cells are an active area of medical research due to their potential to treat diseases. Autologous stem cell transplants involve harvesting a patient's own stem cells, growing more cells, and re-infusing them to help treat diseases and regenerate tissues.
Stem cells have the ability to differentiate into various cell types and can help treat many medical conditions. There are two main types - embryonic stem cells which are pluripotent and can form nearly every cell type, and adult stem cells which are multipotent and usually form a limited number of cell types. Recent research has shown that mature cells can be reprogrammed into pluripotent stem cells through nuclear transfer or the introduction of specific factors. This opens up new possibilities for regenerative medicine and treating diseases.
1) Cell biology is the study of cells, which are the fundamental unit of structure and function in living things. Key discoveries in cell biology include the first observation of cells in the 1600s and the formulation of the cell theory in the 1830s-1840s.
2) Cells come in two main types - prokaryotic cells, which are simpler bacterial cells, and eukaryotic cells, which are more complex and include plant and animal cells. Eukaryotic cells have membrane-bound organelles and a nucleus while prokaryotic cells do not.
3) Stem cells have potential applications in cell replacement therapy and regenerative medicine. Embryonic stem cells are plurip
Kim Solez Renal transplant pathology and future perspectivesKim Solez ,
Dr. Kim Solez presents "Renal transplant pathology and future perspectives" as a TTS webinar on Dec. 8 at noon EST . Includes discussion of the new discipline of tissue engineering pathology. https://www.tts.org/education/advanced-renal-transplantation
Cell is the basic structural and functional unit of living organisms. All known living things are made up of one or more cells, and all cells arise from pre-existing cells through cell division. Important discoveries in cell theory included Hooke discovering cells in 1665, van Leeuwenhoek observing living cells in 1674, and Virchow proposing that all cells come from pre-existing cells in 1855. Cells vary greatly in size, from the smallest bacterial cell at 0.1 micrometers to the largest animal cell, the ostrich egg, at 18 centimeters. Cells also exhibit different shapes depending on their function, such as circular red blood cells for passing through capillaries or branched nerve cells for conducting impulses.
Stem cells and infertility by Dr. GayathiriMorris Jawahar
Stem cells offer potential treatments for many conditions like diabetes, Parkinson's disease and heart disease. Research is focused on better understanding stem cell types like embryonic, adult and induced pluripotent stem cells. Challenges include identifying growth factors, avoiding immune rejection, and safety issues like preventing malignancy. Recent studies show stem cells improving conditions in animal models of diseases like hemophilia and spinal cord injury. Clinical trials are beginning to test stem cell therapies for conditions like ALS. Overall stem cells represent an exciting area of research towards regenerative medicine.
5th year (Blood bank and blood transfusion).pptxMostafaAdelAhmd
The document discusses the history and science of blood banking and transfusion. It covers early attempts at blood transfusions dating back to ancient times. Major milestones include the discovery of the ABO blood group system in 1900 and the Rh system in 1940. The document also examines blood group inheritance and genetics. It provides details on the ABO and Rh blood group systems, including antigens, antibodies, donation compatibility, and inheritance patterns.
The document provides data on plastics production, demand, waste management, and the plastics industry in Europe. Some key points:
- European plastics production in 2013 was 57 million tonnes, similar to levels in 2002. Global production reached 299 million tonnes, up 3.9% from 2012.
- Packaging is the largest application sector for plastics in Europe at 39.6% of total demand. Building and construction is second at 20.3%.
- In 2012, 62% of post-consumer plastics waste in Europe was recovered through recycling or energy recovery, while 38% went to landfill. Since 2006, recycling and energy recovery have increased by 27% and 40% respectively
Platelets play a key role in hemostasis and thrombosis. They become activated when endothelial cells are damaged, adhering to exposed collagen and releasing substances like ADP and thromboxane A2 that amplify recruitment and activation of additional platelets. Activated platelets undergo conformational changes and secrete procoagulant factors from granules, promoting fibrin formation and stabilization of thrombi. Strong agonists like thrombin and collagen induce intracellular signaling leading to aggregation, while weaker agonists like ADP stimulate secondary pathways. Platelets also release inflammatory mediators that can promote endothelial dysfunction. Antiplatelet drugs inhibit pathways of platelet activation to reduce thrombosis.
This document discusses principles of targeted cancer therapy and summarizes several studies. It describes how targeted therapies inhibit specific biological targets expressed by tumor cells, such as the epidermal growth factor receptor (EGFR). The document reviews EGFR inhibitors gefitinib and erlotinib, noting their efficacy in certain patient subgroups. It also discusses acquired resistance to these drugs via secondary mutations and the use of EGFR monoclonal antibodies like cetuximab. Further, it summarizes studies of anti-angiogenic therapy with bevacizumab and describes models used to study angiogenesis.
The document discusses the pathophysiology of the respiratory system. It begins with an overview of breathing and gas exchange. It then covers anatomy and functions of the airways, lungs, and alveoli. Specific conditions like pneumonia, lung cancer, pleural effusion, and cystic fibrosis are examined. Diagnostic tools like bronchoscopy, thoracentesis, and genetic testing are also summarized. The roles of cells like pneumocytes and molecular components like surfactant and the CFTR protein are defined.
This document discusses sepsis and provides information on epidemiology, definitions, pathophysiology, and animal models. It notes that sepsis incidence is rising due to aging populations and increased survival of chronic conditions. Sepsis causes over 200,000 deaths per year in the US, often affecting those with pre-existing conditions. The pathophysiology involves an imbalance between pro-inflammatory and anti-inflammatory responses. Common animal models for studying sepsis include administration of toxins like LPS or live bacteria, or disruption of protective barriers through techniques like cecal ligation and puncture.
This document discusses rheumatoid arthritis (RA) and the evolution of drugs used to treat it. RA is a chronic inflammatory disease that causes joint damage and disability. While the cause is unknown, it involves an immune system response leading to inflammation. Treatment has progressed from nonsteroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs) like methotrexate, to biological DMARDs that target specific cytokines and cells involved in the immune response, such as tumor necrosis factor (TNF) inhibitors and interleukin-6 (IL-6) inhibitors. Larger clinical trials were required to develop these targeted biologic therapies compared to earlier drugs. Animal models of collagen
This document summarizes information about diabetes, including its definition, classification, effects of insulin, and treatments. It begins with an overview of diabetes, defining it as a group of metabolic disorders involving hyperglycemia. It then discusses the two main types of diabetes - type 1 characterized by insulin deficiency and type 2 characterized by insulin resistance - and their causes. Subsequent sections provide details on insulin biosynthesis and secretion, its counter-regulation, effects in different tissues, and role in glucose homeostasis. The document concludes by outlining several classes of medications used to treat diabetes, including sulfonylureas, thiazolidinediones, and newer drugs that target incretin hormones.
Genetically engineered T cells can have extreme toxicities due to their high affinity receptors selecting for on-target, off-tumor activity. One approach to address this issue is to use the antiviral drug acyclovir, which is selectively phosphorylated and activated by the herpes simplex virus thymidine kinase (HSV TK) introduced into the T cells. Only cells expressing HSV TK will be able to convert acyclovir into its toxic form, thereby limiting toxicity to engineered T cells. An alternative approach is to reactivate the diverse natural T cells already present in the tumor microenvironment rather than undergoing complex bioengineering of T cells.
This document discusses adoptive T cell therapy and strategies to harness the adaptive immune system to fight cancer and other diseases. It provides an overview of T cell activation pathways and the role of accessory proteins like CD28 and CD3. It also summarizes methods to engineer T cells, including using tumor-infiltrating lymphocytes and genetically modifying T cells to express chimeric antigen receptors targeting cancers like CD19-positive leukemia. The document discusses approaches like lympho-depletion prior to therapy and highlights some toxicities seen with CAR-T therapy.
Dasatinib is a second-generation BCR-ABL tyrosine kinase inhibitor that is more potent than imatinib and effective against some imatinib-resistant mutations. Unlike imatinib, dasatinib interferes with platelet function by targeting Src family kinases, which may contribute to increased bleeding risk in patients. Clinical trials found dasatinib achieved high rates of cytogenetic and molecular response in chronic myeloid leukemia patients, including those resistant to or intolerant of imatinib. However, dasatinib treatment also carried risks of myelosuppression and bleeding that required dose reductions in some cases.
BIOTECHNOLOGICAL APPLICATIONS 1Therapeutic antibodies 6_humanizationFREE EDUCATION FOR ALL
1. A phase III trial found that ofatumumab plus chemotherapy did not significantly improve progression-free survival compared to rituximab plus chemotherapy for treating relapsed or refractory diffuse large B-cell lymphoma.
2. There were no differences in adverse events between the treatment arms.
3. Based on these results, the companies are unlikely to pursue regulatory approval for ofatumumab in this indication since it did not show a benefit over the standard rituximab treatment.
The document discusses a clinical trial comparing the monoclonal antibodies obinutuzumab and rituximab for treating diffuse large B-cell lymphoma. Obinutuzumab is a glycoengineered, humanized antibody that clusters the CD20 antigen more effectively than rituximab. In a phase III trial, obinutuzumab plus chemotherapy did not significantly improve progression-free survival over rituximab plus chemotherapy. However, obinutuzumab's glycoengineering may enhance its antibody-dependent cellular cytotoxicity and direct cell death mechanisms relative to rituximab.
The document discusses hypoxia-inducible factor (HIF) activation by hypoxia. It describes how hypoxia leads to the activation of HIF, which upregulates genes like VEGF and EPO. It discusses the role of the von Hippel-Lindau tumor suppressor protein and prolyl hydroxylases in the HIF pathway. The document also summarizes VEGF structure and signaling, how it promotes angiogenesis, and the role of differential splicing in producing pro-angiogenic and anti-angiogenic isoforms. Finally, it discusses how anti-angiogenic therapies target tumor vasculature and their limitations.
Rituximab added to CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma significantly improves outcomes including complete response rates, decreases treatment failure and relapse rates, and improves event-free and overall survival compared to CHOP alone, without significantly increasing toxicity. These benefits are sustained over long-term follow up of 10 years. The addition of rituximab improves progression-free and disease-free survival in patients who initially had a complete remission.
CD20 is an excellent target for therapeutic antibodies to treat B cell disorders. Rituximab, a chimeric monoclonal antibody targeting CD20, was found to significantly improve outcomes when added to standard CHOP chemotherapy for B cell lymphoma in elderly patients. Long term follow up of over 10 years confirmed that rituximab extended progression-free and overall survival compared to CHOP alone. Rituximab's success led to further development of monoclonal antibodies for different cancer targets.
The document discusses the development and applications of monoclonal antibodies, including the 1975 discovery of hybridoma technology by Milstein and Köhler which allowed unlimited production of monoclonal antibodies of a single specificity. It then focuses on the development and mechanism of action of the monoclonal antibody Rituximab, the first approved therapeutic monoclonal antibody for treatment of B-cell lymphomas via targeting of the CD20 antigen. The summary also mentions techniques for generating monoclonal antibodies such as hybridoma screening, phage display, and the use of expression vectors for recombinant antibody production.
A crystalline solid possesses rigid and long-range order, with atoms occupying specific positions. An amorphous solid lacks a well-defined arrangement and long-range order. A unit cell is the basic repeating structural unit of a crystalline solid and defines the positions of atoms, molecules, or ions within the structure.
This chapter discusses the structure of crystalline solids. It introduces three common metallic crystal structures - simple cubic, body-centered cubic, and face-centered cubic - and describes their atomic packing arrangements. The chapter also discusses hexagonal close-packed structure and compares the atomic packing factors and densities of each structure. After studying this chapter, readers should understand how atoms are arranged in crystalline materials and be able to analyze and compare different crystal structures.
1. Gene & Cell Therapy
antonia.follenzi@med.uniupo.it
Via Solaroli,17 – Novara
Health Sciences Dept.
Tel. 0321-660674
REGENERATIVE MEDICINE
2. Definition of stem cells: stem cells are unspecialized cells that have two
defining properties: the ability to differentiate into other cells and the ability to
self-regenerate/self-renew
3. This cell
Can form the
Embryo and placenta
This cell
Can just form the
embryo
Fully
mature
4. Stem Cell Types Based on The
Ability to Differentiate
• Totipotent all cell types. E.g.: zygote
• Pluripotent all three germ layers. E.g.:
human embryonic stem cells
• Multipotent many cell types. E.g.:
hematopoietic stem cells
• Unipotent can produce only one cell
type, but have the property of self-renewal
which distinguishes them from non-stem
cells
20. Self-renewal
> 20 passages
Karyotypic stability
Pluripotency
Expression of pluripotency-associated markers
In vitro differentiation
Teratoma formation
Molecular
DNA fingerprinting
Integration of reprogramming transgenes
Silencing of reprogramming transgenes
Reprogramming of gene expression profile
Reprogramming of DNA methylation profile
Criteria for defining bona fide iPS cells
22. Research & Clinical Applications of
Cultured Stem Cells
• Functional genomic studies gene
therapy
• Study of biological processes
development of the organism &
progress of cancer
• Drug discovery & development to
see the properties of the drugs to
differentiated cells
• Cell-based regenerative therapy
25. Stem Cell Characteristics Make Them Good
Candidates for Cell-based Therapies
• Potential to be harvested from patients
• High capacity of cell proliferation in culture to
obtain large number of cells from a limited
source
• Ease of manipulation to replace existing non
functional genes via gene transfer methods
• Ability to migrate to host's target tissues, e.g. the
brain
• Ability to integrate into host tissue and interact
with surrounding tissue
26.
27. Paracelsus
• The fundamental theory behind organ extract andThe fundamental theory behind organ extract and
cell therapy is the principlecell therapy is the principle
‘‘Similia Similibus curanturSimilia Similibus curantur’ or’ or ‘Like Cures Like’‘Like Cures Like’,,
as stated by Paracelsus, a Swiss physician andas stated by Paracelsus, a Swiss physician and
philosopher of the 16philosopher of the 16thth
century. Paracelsus andcentury. Paracelsus and
many other early physicians believed that the bestmany other early physicians believed that the best
way to rebuild or revitalise ill organs or ageingway to rebuild or revitalise ill organs or ageing
tissue was to use healthy living cells of the sametissue was to use healthy living cells of the same
tissue type.tissue type.
28. In 1492, Pope Innocent VIII is said to have received, at the
behest of a Jewish physician, a transfusion of the blood of
three ten year old boys, each of whom was paid a ducat and
all of whom died. Probably the blood was drawn, but was
intended to be taken orally. Indeed, there is no reliable
evidence that the sickly pope accepted the blood at all.
This story has been told and retold over the last half
millennium. It is most likely apocryphal and has the flavor
of an early urban legend in its details and its anti-Semitic and
anti-Catholic overtones.
“First Transfusion” Myth
29. Richard Lower (1631-1691)
Richard Lower is credited with performing, in 1665, the first
authentic blood transfusion (animal to animal).
He kept exsanguinated dogs alive by connecting the carotid
artery of the donor dog to the jugular vein of the recipient dog.
30. Blood Transfusion
• 1818 - James Blundell, a British obstetrician,
performed the first successful transfusion of human
Blood to a patient for the treatment of postpartum
hemorrhage.
– Using the patient's husband as a donor, he extracted a
small amount of Blood from the husband's arm and, using
a syringe, he successfully transfused the wife. Between
1825 and 1830, he performed ten documented
transfusions, five of which proved beneficial to his patients,
and published these results.
31. Karl Landsteiner
1930 Nobel Prize Laureate In 1900, Landsteiner
showed that serum from
some individuals could
agglutinate or hemolyze
the red blood cells of
certain, but not all, other
individuals. The serum of
the latter would likewise
agglutinate the red blood
cells of the former. Still
other individuals’ red cells
were unaffected by the
serum from either of these.
He named these three
different types A, B, and
C. Today these are types
A, B, and O.
32. Dr. Alexis Carrel
• In the late 19th century, the French
Nobel laureate discovered the
potentially immortal nature of cells by
keeping alive fragments of a chicken
heart 25 years after the fowl had died.
33. E. Donnall Thomas
the father of bone marrow transplantation
The spirit of a pioneer
• 1956 – The First Transplantation Between
Identical Twins was performed in Cooperstown,
New York
– Thomas reported that total body irradiation followed
by infusion of marrow from an identical twin could
result in complete remission of leukemia.
34. 1968 – First Bone Marrow Transplant
Between Siblings
In 1968, however, enough was known about the HLA
system for a transplant between siblings to occur. Dr.
Robert A. Good performed the first successful transplant
of this sort at the University of Minnesota:
- the recipient was a four-month-old boy who had inherited
severe combined immunodeficiency syndrome (“bubble boy
syndrome”) and the donor was his eight-year-old HLA-matched
sister. The disease had previously killed 11 male children in the
boy’s family.
35. 1973 – First Unrelated Bone Marrow Transplant
• Expanding knowledge of the HLA-system allowed a
team at Memorial Sloan-Kettering Cancer Center in
New York City to perform the first unrelated bone
marrow transplant in 1973 on a five-year-old patient
suffering from sever combined immunodeficiency
syndrome. The matched donor was found in Denmark
through the Blood Bank at Rigshospitalet in
Copenhagen. The patient received multiple infusions of
marrow, and after the seventh transplant, engraftment
was achieved and hematologic function became normal.
36. Dr. Thomas, wins the 1990 Nobel Prize in Physiology or
Medicine for his pioneering work in the area of organ
and cell transplantation.
October 2012 Dr Thomas died
Editor's Notes
CLICK! This diagram will eventually show the entire range of development, from fertilized egg to mature cell types in the body.
Each cell in the 8-cell embryo, here in red, can generate every cell in the embryo as well as the placenta and extra-embryonic tissues. These cells are called CLICK! TOTIPOTENT stem cells. Why are they called totipotent? (wait for answers) Because one red cell can potentially make all necessary tissues for development. CLICK!
During In Vitro Fertilization, can parents choose whether their baby is going to be a boy or a girl? (wait) Yes, there is a widely-practiced procedure called pre-implantation genetic diagnosis, where one cell is removed from the 8-cell embryo and its DNA is examined. What might you look for when trying to identify the embryo’s sex? (wait) If there’s an X and Y chromosome it’s a boy and if there are two X’s it’s a girl. The parents can decide whether to implant it. Also parents with a genetic disease might want to see if their baby has any identifiable genetic disorders and decide whether to implant based on this information. Pre-implantation genetic diagnosis doesn’t destroy the embryo. Scientists are attempting to adapt this pre-implantation genetic diagnosis procedure and use it to create a stem cell line from one single TOTIPOTENT cell, without destroying the embryo.
The embryonic stem cells inside the blastocyst, here in purple, can generate every cell in the body except placenta and extra-embryonic tissues. These are called CLICK! PLURIPOTENT stem cells…why? (wait for answers) Because they can differentiate into all the 200+ cell types in the body, but they do not form the placenta. CLICK! Pluripotent stem cells can be isolated and grown in culture, or left to develop into more specialized cells in the body.
CLICK! Adult stem cells or tissue-specific stem cells have restricted lineages. Adult stem cells show up when the three distinct layers form in the 14-day-old embryo, and are present in the fetus, baby, child, and so forth. Adult just means they’ve gone further down their lineage pathway than the initial stem cells in the embryo. They are called CLICK! MULTIPOTENT stem cells because they will only become mature cells from the tissue in which they reside. Adult stem cells are present throughout your life and replace fully mature CLICK!, yet damaged and dying cells.
So to review (if time): TOTIPOTENT stem cells come from embryos that are less than 3 days old. These cells can make the TOTAL human being because they can form the placenta and all other tissues. PLURIPOTENT stem cells come from embryos that are 5-14 days old. Embryos and fetuses that are older than 14 days DO NOT contain pluripotent cells. These cells can form every cell type in the body but not the placenta. MULTIPOTENT stem cells are also called adult stem cells and these appear in the 14 day old embryo and beyond. At this point these stem cells will continue down certain lineages and CANNOT naturally turn back into pluripotent cells or switch lineages.